ArticleOpen veterinary journal2025
Antifungal susceptibility testing of
Article in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dermatophytosis: An Update on Global Epidemiology.Journal of fungi (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dermatophytes are fungi that invade keratinized tissues, causing superficial skin lesions in both animals and humans. Although Aim: This study aimed to determine the prevalence and antifungal susceptibility of dermatophyte strains obtained from dermatologically healthy cats in the city of Talca, Chile. Methods: From March 2024 to August 2024, skin or hair samples were collected from three anatomical zones (facial, abdomen, and limbs) of 113 dermatologically healthy cats using the mat technique. Samples were seeded in Sabouraud dextrose agar enriched with chloramphenicol plus cycloheximide and incubated at 25ºC for 21 days. Then, the antifungal sensitivity of the isolated strains was determined by disc diffusion testing, and amphotericin B (10 µg), fluconazole (25 µg), clotrimazole (10 µg), caspofungin (5 µg), voriconazole (1 µg), and nystatin (100 µg) were used as antifungals. The chi-square independence test ( Results: Of the 113 healthy cats included in this study, six (5.3%) were found to be fungal carriers, with Conclusion:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.